Lupa Raises $4M to Modernize Veterinary Care with AI
Lupa, a London-based startup developing an AI-powered veterinary operating system, has raised $4 million in seed funding from investors including …
News
Proscia Grows with 2.4 Million Patients Diagnosed via AI Pathology Platform
Proscia, a company specializing in AI-enabled pathology solutions, reported significant growth in 2024, driven by an increasing demand for enterprise …
AI-Driven Analysis Optimizes Clinical Strategy for A28’s Liver Cancer Peptide Therapy
A28 Therapeutics, a clinical-stage biopharmaceutical company, and GATC Health Corp, a developer of AI-driven drug discovery tools, have announced the …
Umoja Secures $100M For In Vivo CAR-T Therapies
Umoja Biopharma has secured $100 million in an oversubscribed Series C funding round. Based in Seattle, Washington, and founded in …
Eli Lilly Acquires Scorpion Therapeutics' Oncology Program for $2.5 Billion
Eli Lilly announced the acquisition of Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program for up to $2.5 billion, expanding its oncology …
Vevo Therapeutics Plans to Open Source 100M Single-Cell Atlas for Drug Discovery
Vevo Therapeutics has announced plans to open source its Tahoe-100M dataset, described as the world's largest single-cell transcriptomic atlas of …
Bioptimus Reaches $76M Milestone as It Prepares for Next-Gen AI Foundation Model
Bioptimus, a French AI startup, has announced a $76 million funding milestone, with $41 million secured in its latest round …
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
AbCellera has announced an expansion of its collaboration with AbbVie to include the development of T-cell engagers (TCEs) for oncology, …
AbbVie Partners with Simcere on T-Cell Engager for Multiple Myeloma in $1B Deal
AbbVie has partnered with Simcere Zaiming, a subsidiary of Simcere Pharmaceutical, to advance a trispecific antibody candidate, SIM0500, for relapsed …
Truveta Raises $320M to Sequence 10M Exomes and Build Largest Genetic Database
The health data company Truveta, in collaboration with Regeneron and Illumina, and 17 major U.S. health systems, has launched the …
Gilead Strikes $1.7B Deal with LEO Pharma for Oral STAT6 Therapies in Inflammatory Diseases
Gilead Sciences has announced a $1.7 billion collaboration with LEO Pharma, expanding its portfolio beyond infectious diseases and into inflammatory …
Bayer's Cell Therapy for Replacing Dopamine Neurons in Parkinson’s Advances to Phase III
Bayer, through its subsidiary BlueRock Therapeutics, has announced plans to advance bemdaneprocel (BRT-DA01), its investigational pluripotent stem cell-derived dopaminergic neuron therapy …